| Jun 24 |
Insulet plans label expansion for Omnipod in type 2 diabetes
|
| Jun 21 |
Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes
|
| Jun 21 |
Insulet (PODD) Faces Increasing Competition
|
| Jun 21 |
Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System
|
| Jun 20 |
Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands
|
| Jun 20 |
Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates
|
| Jun 19 |
The 3 Best Diabetes Stocks to Buy in June 2024
|
| Jun 17 |
Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field
|
| Jun 17 |
Looking Into Insulet's Recent Short Interest
|
| Jun 13 |
Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now?
|
